-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GbuRjZ/JPamGhqFupJLfF0+ZSFScrkNi/HtY/Ye4X+CgCV1neJUpYWtvnUoAfTj8 yiepqG5W7zZ0zcyHVm1MdQ== 0000905148-08-005250.txt : 20081217 0000905148-08-005250.hdr.sgml : 20081217 20081217184035 ACCESSION NUMBER: 0000905148-08-005250 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20081125 FILED AS OF DATE: 20081217 DATE AS OF CHANGE: 20081217 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSCIENT PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0000356830 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042297484 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 WINTER STREET STREET 2: SUITE 2200 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 7813982300 MAIL ADDRESS: STREET 1: 1000 WINTER STREET STREET 2: SUITE 2200 CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: GENOME THERAPEUTICS CORP DATE OF NAME CHANGE: 19941215 FORMER COMPANY: FORMER CONFORMED NAME: COLLABORATIVE RESEARCH INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Michael Kao CENTRAL INDEX KEY: 0001452251 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-10824 FILM NUMBER: 081256039 BUSINESS ADDRESS: BUSINESS PHONE: 818-883-8270 MAIL ADDRESS: STREET 1: 21700 OXNARD STREET STREET 2: SUITE 1520 CITY: WOODLAND HILLS STATE: CA ZIP: 91367-7584 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AKANTHOS ARBITRAGE MASTER FUND LP CENTRAL INDEX KEY: 0001218962 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-10824 FILM NUMBER: 081256040 BUSINESS ADDRESS: STREET 1: C/O HUNTLAW CORP SERVICES LTD STREET 2: PO BOX 1350GT 75 FORT ST. CITY: GEORGE TOWN GRAND CAYMAN STATE: C8 ZIP: 91367-7584 BUSINESS PHONE: 8184565220 MAIL ADDRESS: STREET 1: C/O APPLEBY TRUST (CAYMAN) LTD. STREET 2: CLIFTON HOUSE,75 FORT ST., P.O. BOX 1350 CITY: GRAND CAYMAN KY1-1108 STATE: E9 ZIP: 00000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AKANTHOS CAPITAL MANAGEMENT LLC CENTRAL INDEX KEY: 0001218957 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-10824 FILM NUMBER: 081256041 BUSINESS ADDRESS: STREET 1: 21700 OXNARD ST STREET 2: SUITE 1520 CITY: WOODLAND HILLS STATE: CA ZIP: 91367-7584 BUSINESS PHONE: 8188838270 MAIL ADDRESS: STREET 1: 21700 OXNARD ST STREET 2: SUITE 1520 CITY: WOODLAND HILLS STATE: CA ZIP: 91367-7584 3/A 1 efc8-1667_ex.xml X0203 3/A 2008-11-25 2008-12-15 0 0000356830 OSCIENT PHARMACEUTICALS CORP OSCI 0001218957 AKANTHOS CAPITAL MANAGEMENT LLC 21700 OXNARD STREET SUITE 1520 WOODLAND HILLS CA 91367-7584 0 0 1 0 0001218962 AKANTHOS ARBITRAGE MASTER FUND LP C/O APPLEBY TRUST (CAYMAN) LTD. CLIFTON HOUSE, 75 FORT ST., PO BOX 1350 GRAND CAYMAN E9 KY1-1108 CAYMAN ISLANDS 0 0 1 0 0001452251 Michael Kao 21700 OXNARD STREET SUITE 1520 WOODLAND HILLS CA 91367-7584 0 0 1 0 COMMON STOCK 1790000 I See Footnotes 12.50% CONVERTIBLE GUARANTEED SENIOR NOTES DUE 2011 COMMON STOCK 6509091 I SEE FOOTNOTES This statement is filed by and on behalf of each of Akanthos Capital Management, LLC ("ACM"), Akanthos Arbitrage Master Fund, L.P. ("AAMF") and Michael Kao (Mr. "Kao"). ACM acts as the investment adviser and general partner to, and manages investment and trading accounts of, other persons, including AAMF. ACM may be deemed, through investment advisory contracts or otherwise, to beneficially own securities owned by other persons, including AAMF. Mr. Kao is the Manager of ACM and may be deemed to beneficially own securities owned by ACM. These shares of the issuer's common stock, par value $.10 per share ("Shares") are held for the account of AAMF. Reporting persons hold approximately 8,299,091 Shares of the issuer, consisting of: (A) 1,790,000 Shares; and (B) 7,160,000 units 12.50% Convertible Guaranteed Senior Notes due 2011 (the "Notes"), convertible at $1.10 per share into 6,509,091 Shares. Reporting persons exceeded the 10% threshold due to an exchange offer (the "Exchange") made by the issuer in which AAMF participated. As per the information provided by the issuer in its Prospectus dated November 24, 2008, prior to the Exchange, on November 3, 2008, the issuer had 14,256,628 Shares outstanding. As per the information provided by the issuer in its Form 8-K dated November 24, 2008, 21,310,549 were issued in the Exchange. Therefore, we understand that the outstanding Shares of the issuer total 35,567,177. The Notes are immediately convertible into Shares. The Notes mature on January 15, 2011, unless earlier converted or repurchased. The initial conversion rate of the Notes is 909.0909 Shares per $1,000 principal amount of Notes (equal to a conversion price of approximately $1.10 per Share). The original Form 3 filed by AAMF and ACM on December 15, 2008 is being amended hereby to include Mr. Kao as a reporting person. With respect to AAMF and ACM, the holdings information included herein is not new or revised, but is being reported again so that the information on all reporting persons' filings will be the same. By: /s/ Michael Kao, Manager of Akanthos Capital Management, LLC, general partner to Akanthos Arbitrage Master Fund, L.P. 2008-12-15 By: /s/ Michael Kao, Manager of Akanthos Capital Management, LLC 2008-12-15 By: /s/ Michael Kao, an individual 2008-12-15 -----END PRIVACY-ENHANCED MESSAGE-----